AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Pertuzumab; Trastuzumab in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Phesgo 600 mg/600 mg/10 mL** Solution for injection | A6-100047 | Roche Products Limited | active | 1 Nov 2027 |
| Phesgo 1200 mg/600 mg/15 mL** Solution for injection | A6-100063 | Roche Products Limited | active | 1 Nov 2027 |
Pertuzumab; Trastuzumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Pertuzumab; Trastuzumab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Pertuzumab; Trastuzumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.